Northern Vascular Systems | Ontario at BioJapan 2025

sfo_preprocess_html() call_user_func_array() (Line: 261) Drupal\Core\Theme\ThemeManager->render() (Line: 490) Drupal\Core\Render\Renderer->doRender() (Line: 248) Drupal\Core\Render\Renderer->render() (Line: 158) Drupal\Core\Render\MainContent\HtmlRenderer->{closure:Drupal\Core\Render\MainContent\HtmlRenderer::renderResponse():153}() (Line: 637) Drupal\Core\Render\Renderer->executeInRenderContext() (Line: 153) Drupal\Core\Render\MainContent\HtmlRenderer->renderResponse() (Line: 90) Drupal\Core\EventSubscriber\MainContentViewSubscriber->onViewRenderArray() call_user_func() (Line: 111) Drupal\Component\EventDispatcher\ContainerAwareEventDispatcher->dispatch() (Line: 186) Symfony\Component\HttpKernel\HttpKernel->handleRaw() (Line: 76) Symfony\Component\HttpKernel\HttpKernel->handle() (Line: 53) Drupal\Core\StackMiddleware\Session->handle() (Line: 48) Drupal\Core\StackMiddleware\KernelPreHandle->handle() (Line: 28) Drupal\Core\StackMiddleware\ContentLength->handle() (Line: 32) Drupal\big_pipe\StackMiddleware\ContentLength->handle() (Line: 201) Drupal\page_cache\StackMiddleware\PageCache->fetch() (Line: 138) Drupal\page_cache\StackMiddleware\PageCache->lookup() (Line: 87) Drupal\page_cache\StackMiddleware\PageCache->handle() (Line: 48) Drupal\Core\StackMiddleware\ReverseProxyMiddleware->handle() (Line: 51) Drupal\Core\StackMiddleware\NegotiationMiddleware->handle() (Line: 36) Drupal\Core\StackMiddleware\AjaxPageState->handle() (Line: 51) Drupal\Core\StackMiddleware\StackedHttpKernel->handle() (Line: 741) Drupal\Core\DrupalKernel->handle() (Line: 19)

Profile

Northern Vascular Systems (NVS) has pioneered a novel, light-activated gel for treatment of vascular disorders such as tumours, arteriovenous malformations, and aneurysms. The gel is non-toxic, water-soluble, and cures on demand only when exposed to the correct wavelength of light, allowing clinicians greater control and flexibility in the treatment of complex vascular pathologies, and control over when and where occlusion occurs. Delivery occurs through its custom microcatheter which is <0.8mm in size, and allows for simultaneous delivery of the gel and activating light, allowing it to fit seamlessly into existing clinical practice.

Northern Vascular was co-founded by four members. Yuta Dobashi (CTO) – creator of the technology during his Doctoral Thesis, and Joel Ramjist (CEO) – research coordinator for the group from which the technology was developed, run day-to-day operations of the company. Joining the founding team is Dr. Victor Yang – neurosurgeon-engineer and co-founder of 7D Surgical (sold in 2021 for $110M USD), Dr. Konrad Walus, Professor of Engineering and co-founder of Aspect Biosystems – one of the world’s foremost bio3D printing companies. NVS has assembled a unique and experienced team to take this technology to market, and with significant pre-clinical data, is poised to enter First-in-Human studies in the coming 6 months.

northvasc.com

Contact

Joel Ramjist, Chief Executive Officer

Tel: +1 647-278-5635

Email: j.ramjist@northvasc.com

Event details

Name: Ontario at BioJapan 2025

Date: October 8 - 10, 2025

Event contact

Stephen Ip

Senior International Market Consultant

Japan and Korea

+1 437-339-1529

stephen.ip@ontario.ca

Participants

6 in total

ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for life…
Copoly.ai is a Canadian biotechnology and AI company redefining early cancer detection…
Dalriada is a leading North American partnered discovery company that is pioneering its novel Turn-Key™ model in small…
DistillerSR is the leading platform for AI powered literature review automation and evidence…
Northern Vascular Systems (NVS) has pioneered a novel, light-activated gel for treatment of vascular…
Rapid Novor Inc. is a leading CRO specializing in antibody…

Error message

Profile

Website

Contact

Event details

Event contact